Loading Page
Dr. Scott A. Waldman, MD, PhD is an internist in Philadelphia, PA specializing in internal medicine (adult medicine) and clinical pharmacology. He graduated from Stanford University School of Medicine. Dr. Scott A. Waldman, MD, PhD is affiliated with Jefferson Health and Thomas Jefferson University Hospital.
Thomas Jefferson University Hospital
Dr. Scott A. Waldman, MD, PhD graduated from Stanford University School of Medicine. He completed residency at Stanford Hospital & Clinics. He is certified by the Board Certification: Clinical Pharmacology and has a state license in Pennsylvania.
Medical School: Stanford University School of Medicine
Residency: Stanford Hospital & Clinics
Board Certification: Board Certification: Clinical Pharmacology
Licensed In: Pennsylvania
Dr. Scott A. Waldman, MD, PhD is associated with these hospitals and organizations:
Dr. Scott A. Waldman, MD, PhD appears to accept the following insurance providers: Geisinger Health Plan, Humana and Aetna Medicare.
According to our sources, Dr. Scott A. Waldman, MD, PhD accepts the following insurance providers:
Dr. Scott A. Waldman, MD, PhD does not have any reviews yet, be the first to leave a review of Dr. Scott A. Waldman, MD, PhD here: Leave a Review
These charts describe general payments received by Dr. Scott A. Waldman, MD, PhD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$17,982
Trulance $17,982 |
|
|
$1,500
$1,500 |
|
|
$21
$21 |
| $14,700 | |
| $2,748 | |
| $1,500 | |
| $556 |
Dr. Scott A. Waldman, MD, PhD has received 3 research payments totaling $47,909.
Dr. Scott Waldman's medical specialty is clinical pharmacology. Dr. Waldman graduated from Stanford University School of Medicine. His medical residency was performed at Stanford Hospital & Clinics. He appears to be in-network for Aetna Medicare, Humana, Geisinger Health Plan, and more. He is affiliated with Thomas Jefferson University Hospital. Jefferson Health reports that Dr. Waldman is closed to new patients at this time.
